|
CPOX expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.262200E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.311750E-02 |
| Normal-vs-Stage2 |
2.589600E-01 |
| Normal-vs-Stage3 |
1.875190E-03 |
| Normal-vs-Stage4 |
8.255800E-03 |
| Stage1-vs-Stage2 |
6.839800E-01 |
| Stage1-vs-Stage3 |
1.520350E-01 |
| Stage1-vs-Stage4 |
2.502800E-01 |
| Stage2-vs-Stage3 |
2.203400E-01 |
| Stage2-vs-Stage4 |
2.802400E-01 |
| Stage3-vs-Stage4 |
9.465400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.637100E-04 |
| Normal-vs-AfricanAmerican |
5.619400E-01 |
| Normal-vs-Asian |
1.852450E-01 |
| Caucasian-vs-AfricanAmerican |
1.801160E-01 |
| Caucasian-vs-Asian |
2.875200E-01 |
| AfricanAmerican-vs-Asian |
6.954200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.138000E-02 |
| Normal-vs-Female |
1.620000E-03 |
| Male-vs-Female |
4.321000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.410300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.037880E-03 |
| Normal-vs-Age(61-80Yrs) |
6.978900E-03 |
| Normal-vs-Age(81-100Yrs) |
1.243030E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.400760E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.915000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.965600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.075200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.095000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.459000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.617700E-02 |
| Classical-VS-Follicular |
8.413900E-02 |
| Classical-VS-Other |
6.008600E-01 |
| Classical-VS-Normal |
5.140200E-03 |
| Tall-VS-Follicular |
2.862700E-03 |
| Tall-VS-Other |
9.945700E-02 |
| Tall-VS-Normal |
1.199510E-04 |
| Follicular-VS-Other |
9.521800E-01 |
| Follicular-VS-Normal |
4.613600E-01 |
| Other-VS-Normal |
6.247600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.104110E-02 |
| Normal-vs-N1 |
4.895600E-03 |
| N0-vs-N1 |
3.211800E-01 |
|
|
